Skip to content

Comparing the effectiveness of remineralizing agents, Tooth Mousse and Toothmin on salivary pH and flow rate

Comparative Evaluation of Two Remineralizing Agents on Salivary pH and Salivary Flow Rate An in vivo study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090133
Enrollment
40
Registered
2025-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Tooth Mousse: The investigational products is Tooth Mousse. This product is known for its remineralization potential. This paste contains Casein Phosphopeptide-Amorphous Calcium Phospha

Sponsors

Vedashree Chaudhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 6-9 years of age reporting to the Department of Pediatric and Preventive Dentistry as well as patients from organized school dental camps. Participants should not have any dental caries (code 0 according to ICDAS-II). Participants parents who give consent to participate in the study.

Exclusion criteria

Exclusion criteria: Any systemic disease that affect flow rate of saliva. Patients undergoing orthodontic treatment. Patients taking any antibiotics or any kind of medications past 1 month that can affect the salivary flow rate. Patients having confirmed or suspected allergy to proteins. Patients with special health care needs, calcium or phosphate deficiency.

Design outcomes

Primary

MeasureTime frame
To evaluate and compare the Salivary pH and Salivary Flow Rate using Toothmin (Abbott) and GC Tooth Mousse. Timepoint: 6 months

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactLalit Patil

Dr. D.Y. Patil Dental College and Hospital, Pimpri, Pune

drlalitpatil47@gmail.com9765370827

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026